The Patent Finder

AbbVie Stemcentrx LLC

Also on record
Records under this name other than the patents AbbVie Stemcentrx LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Back to AbbVie Stemcentrx LLC

PatentTitleStatus Expires Confidence
US 10,035,853Site-Specific Antibody Conjugation Methods and Compositions
Lapsed on the fee record
Ended Jul 31, 2026 · High confidence
Lapsed on the fee recordEnded Jul 31, 2026High confidence
US 9,914,784PTK7 modulators and methods of use
Lapsed on the fee record
Ended Mar 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2026From the USPTO record
US 9,878,053Methods of delivering DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Jan 30, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 30, 2026From the USPTO record
US 9,867,887Anti-DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Jan 16, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 16, 2026From the USPTO record
US 9,861,708Kits containing DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Jan 9, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 9, 2026From the USPTO record
US 9,855,343Anti-DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Jan 2, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 2, 2026From the USPTO record
US 9,775,916Anti-DLL3 antibody drug conjugates for treating cancer
Lapsed on the fee record
Ended Oct 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2025From the USPTO record
US 9,770,518Anti-DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Sep 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 26, 2025From the USPTO record
US 9,764,042Methods of making DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Sep 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Sep 19, 2025From the USPTO record
US 9,486,537Anti-DLL3 antibody drug conjugates
Lapsed on the fee record
Ended Nov 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 8, 2024From the USPTO record
10 of 41 patents shown.
Pro members see all 41.
Pro members: see all 41 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited